Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PC Pharma CVA peri-operative cardioprotection in aortic valve surgery
2008-003973-42Phase 3Active
- Sponsor
- Hospices Civils de Lyon
- Start
- Jul 2008
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial of sevoflurane and cyclosporine in aortic valve disease (AVD), aortic stenosis (AS) and aortic insufficiency (AI) (3 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Postoperative peak troponin I within 72 hours. Started Jul 2008; status: active.
02
Drugs
sevofluranecyclosporine
03
Conditions
aortic valve disease (AVD)aortic stenosis (AS)aortic insufficiency (AI)
Beyond the preview
Go deeper on 2008-003973-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003973-42.